High expression of CD73 as a poor prognostic biomarker in human colorectal cancer

Journal of Surgical Oncology

Volumn 106, Issue 2, 2012, Pages 130-137

  Wu, Xian Rui ^a   He, Xiao Sheng ^a   Chen, Yu Feng ^a   Yuan, Rui Xue ^a   Zeng, Yang ^a   Lian, Lei ^a   Zou, Yi Feng ^a   Lan, Nan ^b   Wu, Xiao Jian ^a   Lan, Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

CD73; colorectal neoplasms; prognosis

Indexed keywords

5' NUCLEOTIDASE;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

5'-NUCLEOTIDASE; ADULT; AGED; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN ARRAY ANALYSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84863722239     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23056     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Mitry E, Rachet B, Quinn MJ, et al.: Survival from cancer of the rectum in England and Wales up to 2001. Br J Cancer 2008; 99: S30-S32.
3. Brenner H, Bouvier AM, Foschi R, et al.: Progress in colorectal cancer survival in Europe, from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2011; [Epub ahead of print].
4. Nagtegaal ID, Quirke P:, Revised staging: Is it really better, or do we not know ? J Clin Oncol 2010; 28: e397-398; author reply e399-e400.
5. Ratto C, Ricci R:, Potential pitfalls concerning colorectal cancer classification in the seventh edition of the AJCC Cancer Staging Manual. Dis Colon Rectum 2011; 54: e232.
6. Thirunavukarasu P, Sukumar S, Sathaiah M, et al.: C-stage in colon cancer: Implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. J Natl Cancer Inst 2011; 103: 689-697.
7. Zhang B:, CD73: A novel target for cancer immunotherapy. Cancer Res 2010; 70: 6407-6411.
8. Stagg J, Smyth MJ:, Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010; 29: 5346-5358.
9. Salmi M, Jalkanen S:, Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread. FEBS Lett 2011; 585: 1543-1550.
10. Resta R, Yamashita Y, Thompson LF:, Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 1998; 161: 95-109.
11. Colgan SP, Eltzschig HK, Eckle T, et al.: Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006; 2: 351-360.
12. Synnestvedt K, Furuta GT, Comerford KM, et al.: Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002; 110: 993-1002.
13. Niemela J, Henttinen T, Yegutkin GG, et al.: IFN-alpha induced adenosine production on the endothelium: A mechanism mediated by CD73 (ecto-5'- nucleotidase) up-regulation. J Immunol 2004; 172: 1646-1653. (Pubitemid 38116812)
14. Spychala J, Kitajewski J:, Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Exp Cell Res 2004; 296: 99-108. (Pubitemid 38624632)
15. Hausler SF, Montalban Del Barrio I, Strohschein J, et al.: Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Cancer Immunol Immunother 2011; 60: 1405-1418.
16. Kondo T, Nakazawa T, Murata SI, et al.: Expression of CD73 and its ecto-5'-nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology 2006; 48: 612-614.
17. Gocmen E, Tez M, Ozturk S, et al.: Activities of adenosine deaminase and 5'-nucleotidase in cancereous and non-cancereous human gastric tissues. Bratisl Lek Listy 2009; 110: 416-418.
18. Spychala J, Lazarowski E, Ostapkowicz A, et al.: Role of estrogen receptor in the regulation of ecto-5'-nucleotidase and adenosine in breast cancer. Clin Cancer Res 2004; 10: 708-717. (Pubitemid 38174010)
19. Eroglu A, Canbolat O, Demirci S, et al.: Activities of adenosine deaminase and 5'-nucleotidase in cancerous and noncancerous human colorectal tissues. Med Oncol 2000; 17: 319-324.
20. Camp RL, Dolled-Filhart M, Rimm DL:, X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004; 10: 7252-7259. (Pubitemid 39487712)
21. Cai MY, Hou JH, Rao HL, et al.: High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol Med 2011; 17: 12-20.
22. Raeside DE:, Monte Carlo principles and applications. Phys Med Biol 1976; 21: 181-197.
23. O'Connell JB, Maggard MA, Ko CY:, Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420-1425. (Pubitemid 39429665)
24. Huang Y, Li W, Chu D, et al.: Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer. J Gastrointest Surg 2011; 15: 1188-1194.
25. Lin KY, Tai C, Hsu JC, et al.: Overexpression of nuclear protein kinase CK2 alpha catalytic subunit (CK2alpha) as a poor prognosticator in human colorectal cancer. PLoS ONE 2011; 6: e17193.
26. Lin AY, Chua MS, Choi YL, et al.: Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS ONE 2011; 6: e16636.
27. Galon J, Costes A, Sanchez-Cabo F, et al.: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964. (Pubitemid 44498003)
28. Salama P, Phillips M, Grieu F, et al.: Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009; 27: 186-192.
29. Nosho K, Baba Y, Tanaka N, et al.: Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: Cohort study and literature review. J Pathol 2010; 222: 350-366.
30. Zhi X, Wang Y, Zhou X, et al.: RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells. Cancer Sci 2010; 101: 2561-2569.
31. Jin D, Fan J, Wang L, et al.: CD73 on tumor cells impairs antitumor T-cell responses: A novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70: 2245-2255.
32. Stagg J, Divisekera U, McLaughlin N, et al.: Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA 2010; 107: 1547-1552.
33. Stagg J, Divisekera U, Duret H, et al.: CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res 2011; 71: 2892-2900.
34. Wang L, Fan J, Thompson LF, et al.: CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 2011; 121: 2371-2382.
35. Yegutkin GG, Marttila-Ichihara F, Karikoski M, et al.: Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. Eur J Immunol 2011; 41: 1231-1241.
36. Ludwig HC, Rausch S, Schallock K, et al.: Expression of CD 73 (ecto-5'-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. Anticancer Res 1999; 19: 1747-1752. (Pubitemid 29392731)
37. Durak I, Cetin R, Canbolat O, et al.: Adenosine deaminase, 5'-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer. Cancer Lett 1994; 84: 199-202.